The refined compliance model is designed to aggressively reduce potential or perceived conflicts of interest inherent in consulting relationships between the industry and healthcare professionals—while preserving the best of the collaboration that drives innovation in medical devices and services. The model includes fundamental changes in the areas of product development, marketing, surgeon training, educational and charitable funding, and transparency.Click here to access.
Saturday, April 19, 2008
Looks like at least one medical device manufacturer is responding just like Big Pharma! An excerpt from Zimmer's recent announcement: